Volume 9, Issue 1 (3-2023)
CJP 2023, 9(1): e12 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kalenahalli J, Hassan Vasudev P, Vadambal Gopalakrishna M, Huchhavanahalli Rudrappa N. Severe Bradycardia caused by Octreotide in an Adolescent: A Case Report. CJP 2023; 9 (1) :12-12
URL: http://caspianjp.ir/article-1-209-en.html
URL: http://caspianjp.ir/article-1-209-en.html
Jagadishkumar Kalenahalli 
, Prajwala Hassan Vasudev , Manjunath Vadambal Gopalakrishna , Nandish Huchhavanahalli Rudrappa
, Prajwala Hassan Vasudev , Manjunath Vadambal Gopalakrishna , Nandish Huchhavanahalli Rudrappa
MBBS., MD; Professor of Pediatrics, Jss Medical College, Jss Academy of Higher Education and Research, Mysore, India , kjagadishkumar@jssuni.edu.in
Abstract: (1648 Views)
Background and Objective: Octreotide is a somatostatin analogue used to control upper gastrointestinal (GI) bleeding. Adverse effects observed include hyperglycemia, growth hormone deficiency, hypertension, Q-T interval prolongation, and ventricular fibrillation. In rare cases, mild bradycardia has been reported.
Case Report: A 16-year-old boy was admitted with shock due to hematemesis and melena a bleeding duodenal ulcer. He was treated with an intravenous venous octreotide infusion at a dose of 1 microgram/kg/hour, and bleeding was controlled with coagulation forceps and adrenaline injection. Because of rebleeding, octreotide was increased to 2 micrograms/kg/hour because of bleeding again. After 24 hours, he developed severe bradycardia (pulse rate (PR) 45/minute). His PR increased to 66/minute by 12 hours after octreotide was discontinued.
Conclusion: Octreotide can cause significant cardiovascular side effects. Bradycardia and cardiac conduction blocks may affect the hemodynamics of a child with acute GI bleeding.
Case Report: A 16-year-old boy was admitted with shock due to hematemesis and melena a bleeding duodenal ulcer. He was treated with an intravenous venous octreotide infusion at a dose of 1 microgram/kg/hour, and bleeding was controlled with coagulation forceps and adrenaline injection. Because of rebleeding, octreotide was increased to 2 micrograms/kg/hour because of bleeding again. After 24 hours, he developed severe bradycardia (pulse rate (PR) 45/minute). His PR increased to 66/minute by 12 hours after octreotide was discontinued.
Conclusion: Octreotide can cause significant cardiovascular side effects. Bradycardia and cardiac conduction blocks may affect the hemodynamics of a child with acute GI bleeding.
Type of Study: case report |
Subject:
General
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
